Evidence for a Growth-Stabilizing Regulatory Feedback Mechanism between Myc and Yorkie, the Drosophila Homolog of Yap  by Neto-Silva, Ricardo M. et al.
Developmental Cell
ArticleEvidence for a Growth-Stabilizing Regulatory
Feedback Mechanism between Myc and Yorkie,
the Drosophila Homolog of Yap
Ricardo M. Neto-Silva,1,2 Simon de Beco,2 and Laura A. Johnston2,*
1Gulbenkian PhD Program in Biomedicine, P-2780-156 Oeiras, Portugal
2Department of Genetics and Development, Columbia University Medical Center, 701 West 168th Street, New York, NY 10032, USA
*Correspondence: lj180@columbia.edu
DOI 10.1016/j.devcel.2010.09.009SUMMARY
An understanding of how animal size is controlled
requires knowledge of how positive and negative
growth regulatory signalsarebalancedand integrated
within cells. Herewedemonstrate that the activities of
the conserved growth-promoting transcription factor
Myc and the tumor-suppressing Hippo pathway are
codependent during growth of Drosophila imaginal
discs. We find that Yorkie (Yki), the Drosophila
homologof theHippopathway transducer, Yap, regu-
lates the transcription of Myc, and that Myc functions
asacritical cellulargrowtheffectorof thepathway.We
demonstrate that in turn, Myc regulates the expres-
sion of Yki as a function of its own cellular level,
such that high levels of Myc repress Yki expression
through both transcriptional and posttranscriptional
mechanisms.Wepropose that thecodependent regu-
latory relationship functionally coordinates the
cellular activities of Yki andMyc andprovides amech-
anism of growth control that regulates organ size and
has broad implications for cancer.
INTRODUCTION
Animal growth is controlled by regulatory pathways that promote
tissue expansion and also by those that limit it. Amajor challenge
to our understanding of size control is how the positive and nega-
tive forces are balanced to prevent aberrant growth and restrict
organ and body size to a norm. Two keymediators of size control
are the cellular growth promoter Myc and the Hippo (Hpo) tumor
suppressor pathway. Their critical roles in regulating organ size
are well conserved, and both are frequently deregulated in
human cancer (de la Cova and Johnston, 2006; Pan, 2007;
Zeng and Hong, 2008), but if and how these pathways intersect
during growth regulation is unknown.
Myc is a functionally conserved transcriptional regulator that
drives cellular growth by activating numerous target genes
(de la Cova and Johnston, 2006; Vita and Henriksson, 2006).
In mammals Myc functions as an oncogene in a vast array of
tumors and is also required for growth during normal develop-
ment and in regeneration. Much of Myc’s power as a growthDevelopmpromoter stems from its regulation of genes that promote
ribosome assembly (Grandori et al., 2005; Grewal et al., 2005).
The Hpo pathway, in both flies and mammals, restricts growth
by retaining the transcriptional coactivator, Yorkie (Yki)/Yap in
the cytoplasm through a phosphorylation cascade regulated
by the conserved kinases Hpo/Mst1 and Warts/Lats, in
association with the scaffolding proteins Sav/WW45 and Mats
(Pan, 2007). Reduced Hpo activity allows nuclear translocation
of Yki/Yap and its association with DNA binding proteins and
transcriptional activation of target genes that regulate cell prolif-
eration and tissue growth. Much of the Hpo pathway was first
elucidated in Drosophila, where its targets include the anti-
apoptotic factor dIAP1, the cell cycle regulator cyclin E, and
bantam, a Drosophila-specific microRNA with anti-apoptotic
and growth-promoting functions (Huang et al., 2005; Nolo
et al., 2006; Tapon et al., 2002; Thompson and Cohen, 2006;
Wu et al., 2003). Additional targets include upstream regulators
such as the FERM domain proteins Expanded (Ex)/FRMD6 and
Merlin/NF2, and the Golgi kinase Four Jointed (FJ)/Fjx1 (Badouel
et al., 2009a; Reddy and Irvine, 2008). A recent report indicates
that the patterning system of the Drosophila wing imaginal disc
modulates Hpo activity through regulation of the association of
Fat with Ds (Rogulja et al., 2008).
The cell survival and cell division targets regulated by the Hpo
pathway clearly contribute to its control of size, yet specific and
conserved growth regulatory targets have remained elusive. The
extensive functional conservation of components of the Hpo
pathway suggests that a generally conserved growth factor is
subject to its regulation. Here we provide evidence that
Drosophila Myc is a transcriptional target of Yki and functions
as a critical cellular growth effector of the pathway. Furthermore,
we demonstrate that in a negative feedback loop, dMyc modu-
lates Yki expression and activity as a function of its own level,
suggesting that dMyc can adjust overall growth rates by
affecting Hpo pathway activity. Based on our results, we
propose that a negative feedback loop between Hpo pathway
signaling and dMyc provides a stabilizing, homeostatic mecha-
nism that contributes to regulation of organ size.RESULTS
dMyc Is Required for Yki to Promote Growth
Growth control in Drosophila imaginal discs, the epithelial
primordia that give rise to the body of the adult fly, requires theental Cell 19, 507–520, October 19, 2010 ª2010 Elsevier Inc. 507
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utive (dm) gene. Disc cells homozygous for the dm4 null mutation
proliferate very poorly and form small, infrequently recovered
clones (Figures 1B and 1E), whereas dMyc overexpression
increases cellular growth and leads to an increase in tissue
mass due to larger cell size (Johnston et al., 1999; Wu and
Johnston, 2010). Cell clones that overexpress Yki or carry muta-
tions that inactivate its inhibitor, Wts, grow large via increased
cell proliferation and can occupy large territories of wing and
eye discs (Figures 1C, 1H, 2B, and 2C) (Wu et al., 2003). We
tested the possibility that the increase in Yki-driven growth
required the function of dMyc. We used the dm4 null allele in
MARCM (mosaic analysis with a repressible marker) experi-
ments, which couples Gal4-UAS control of gene expression to
the generation of cell clones by mitotic recombination (Lee and
Luo, 1999), to assess whether Yki expression could promote
growth of clones in which dMyc function was specifically
deleted. Measurement of clone size after defined periods of
time indicated that whereas UAS-yki stimulated the growth of
wild-type cells (Figures 1C and 1E), it was completely unable
to promote growth in the absence of dMyc. dm4 mutant cell
clones expressing UAS-yki were no larger than dm4 clones
expressing UAS-GFP, even when a dominant negative form of
the Dronc caspase (UAS-droncCD) (Meier et al., 2000) was
expressed with Yki to prevent their death (Figures 1D and 1E).
Thus, dMyc function is necessary for Yki expression to stimulate
tissue growth, suggesting that dMyc is an important effector of
growth downstream of the Hpo pathway.
In addition to its cell autonomous growth-regulatory functions,
dMyc influences tissue size noncell autonomously by driving cell
competition, a homeostatic process that arises from local
cellular differences in expression of dMyc or genes encoding
ribosomal proteins (Rps) (Johnston, 2009). During competition
in Drosophila, ‘‘loser’’ cells are instructed by ‘‘winner’’ cells to
undergo apoptosis and are eliminated from the epithelium. Inter-
estingly, mutations that inactivate the Hpo pathway can
suppress the loss of rpl36/+ loser cells in competitive mosaics
(Tyler et al., 2007). In competition induced by Rp differences,
winner cells replace dying loser cells by proliferating at a normal
rate during an extended growth period (Martin et al., 2009). In
contrast winner cells in dMyc-induced competition are stimu-
lated to proliferate faster to replace loss of the loser cells
(Senoo-Matsuda and Johnston, 2007; Wu and Johnston,
2010). To test whether inactivation of the Hpo pathway led to
cell competition, we generated marked wild-type and ykiB5 null
mutant sibling cell clones byMARCMandmeasured their growth
(de la Cova et al., 2004). During a given growth period, ykiB5
mutant clones grew extremely poorly, but their wild-type sibling
clones grew significantly more than control sibling clones
(Figures 1F, 1G, and 1I). This faster rate of growth is a hallmark
of winner behavior in dMyc-induced competition (Johnston,
2009). In addition wild-type cell clones grew poorly when next
to cell clones expressing UAS-yki (Figures 1H and 1J). The loser
behavior of thewild-type cells wasmost likely due to a significant
increase in cell death (see Figure S1 available online). The
apoptosis of losers and enhanced growth of winners when cells
differ in Hpo activity specifically phenocopies competition
induced by differences in dMyc expression (de la Cova et al.,
2004; Senoo-Matsuda and Johnston, 2007; Wu and Johnston,508 Developmental Cell 19, 507–520, October 19, 2010 ª2010 Elsev2010). In light of the requirement for dMyc in clonal growth
promoted by Yki expression, these data suggest that local
perturbations of the Hpo pathway can create differences in
dMyc expression between neighboring cells, and provoke cell
competition. This possibility led us to examine whether Hpo
activity regulates expression of dMyc.
Hpo Signaling Activity Regulates dMyc Expression
To determine whether changes in Hpo signaling activity affect
dmyc expression, we repressed Hpo pathway activity by gener-
ating clones of wts mutant cells or bypassed it with flp-out Gal4
clones of cells expressing UAS-yki. In the majority of these
clones, dMyc protein was substantially upregulated in multiple
tissues, including the wing, leg, antenna, and eye imaginal discs.
dMyc was also induced in cells that normally express little or
no dMyc (Figures 2A–2C; Figures S2A and S2B). Furthermore,
dmyc mRNA was induced in cells overexpressing UAS-yki
(Figures 2E and 2F), suggesting that loss of Hpo activity leads
to transcriptional activation of the dm gene. Conversely, expres-
sion of UAS-hpo, along with the caspase inhibitor P35 to prevent
cell death, sharply decreased endogenous dmyc expression
(Figures 2D and 2D00. Thus, low Hpo activity is sufficient to acti-
vate dmyc expression and high Hpo activity to repress it. These
observations confirm that endogenous expression of dmyc is
controlled by the activity of the Hpo signaling pathway.
Yki and Scalloped Physically Associate
with the dm Locus
Yki is a potent transcriptional coactivator but requires a DNA
binding partner to activate target gene transcription. Two DNA
binding factors, the TEAD family protein, Scalloped (Sd), and
the Hox cofactor, Homothorax (Hth), are known to form
complexes with Yki to promote target gene activation in
Drosophila (Peng et al., 2009; Wu et al., 2008). Sd is required
for the growth and survival of cells in the central portion of the
disc (the wing pouch) where dMyc is most highly expressed,
and clones of sd null mutant cells are rarely recovered there
(data not shown) (Liu et al., 2000). Therefore, we examined the
role of Sd in regulation of dMyc using a short-hairpin (sh) RNA
to reduce sd expression (Figures 3A–3C). UAS-dicer2 was
included to potentiate shRNA silencing. When UAS-sd shRNA
was expressed medially in the disc with DppGal4, dMyc
expression was substantially reduced (Figures 3A and 3A0).
This effect was specific to dMyc because expression of Nubbin,
another nuclear factor expressed in the wing pouch, was not
substantially altered (Figure 3A00). In addition expression of
UAS-sd shRNA andUAS-yki together in flp-out clones prevented
the ability of UAS-yki to increase dMyc expression in its endog-
enous expression domain and also prevented its ectopic
induction (Figures 3B and 3C). In contrast, expression of
a UAS-shRNA against hth did not alter dMyc expression in any
region of the disc (data not shown). Thus, both Yki and Sd are
required for control of dmyc expression in the wing disc, raising
the possibility that the two factors cooperate in its transcriptional
activation.
To determinewhether the dm locus is directly controlled by the
Hpo pathway, we first searched for Sd binding sites in the dm
gene and found potential matches at various positions along
the locus (Figure 3 and data not shown). Three sites mappedier Inc.
Figure 1. Yki Requires dMyc for Growth and Local Differences in Hpo Activity Induce Cell Competition
(A–E) Loss of dMyc prevents Yki-induced growth. MARCM clones generated in wing discs, marked by T80Gal4 > UAS-GFP expression (green). (A) Control
clones. (B) dm4 mutant clones. (C) UAS-yki-expressing clones. (D) dm4 mutant clones that express UAS-yki. (E) Quantification of mean clone size. UAS-yki-ex-
pressing clones (gray bar) induce significant growth relative to control clones (black bar), but its expression fails to induce growth in dm4 mutant cells (dark gray
bar), even when death is prevented by UAS-droncCD expression (white bar). Error bars in this and all subsequent figures are standard error of the mean (SEM).
(F–J) Measurement of cell competition using MARCM in wing discs to generate a Gal4/UAS-GFP-expressing clone (green) and its sibling clone (marked with two
copies of CD2, magenta). (F) Control TubGal4 > UAS-GFP clone and wild-type (wt) CD2 sibling showing that wt sibling clones grow equally well. (G) ykiB5mutant
TubGal4 > UAS-GFP clone and wt CD2 sibling. (H) UAS-yki-expressing TubGal4 > UAS-GFP clone and wt CD2 sibling. (I and J) Quantification of cell competition.
(I) ykiB5mutant TubGal4 > UAS-GFP clones grow less than control wt TubGal4 > UAS-GFP clones (green bars) and are competed against by their wt and hetero-
zygous neighbors, whereas their wt CD2 sibling clones grow significantly more than control CD2 sibling clones (magenta bars), an indication of ‘‘winner’’ status.
(J) UAS-yki-expressing TubGal4 > UAS-GFP clones grow more than control TubGal4 > UAS-GFP clones (green bars), whereas their wt sibling CD2 clones are
smaller than control wt sibling CD2 clones (magenta bars), indicative of ‘‘loser’’ status. See also Figure S1. p values, *p < 0.05; ***p < 0.001. In this and all subse-
quent figures, discs are oriented with dorsal up and posterior to the right.
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Figure 2. Hpo Signaling Activity Regulates
dMyc Expression
(A) Control wing disc with ActGal4 >GFP-express-
ing clones (green) showing wild-type dMyc
expression (magenta) (A0).
(B) Clonal expression of UAS-yki (green) upregu-
lates dMyc expression (magenta) in endogenous
regions and induces it ectopically. Note that
clones at the dorso-ventral boundary (arrowhead
in B0) do not express dMyc due to dominant
patterning cues (Johnston et al., 1999).
(C) Clones ofwtsx1mutant cells (absence of green)
induce expression of dMyc.
(D) Wing disc expressing UAS-hpo and UAS-p35
under DppGal4 control (green). dMyc is specifi-
cally downregulated by UAS-hpo expression
(arrowhead, D0), whereas Nub expression (blue),
which is expressed throughout the wing pouch,
is unaffected (arrowhead, D00). See also
Figure S2. (E and F) dmyc mRNA in control wing
disc (E) or wing disc that expresses UAS-yki in
posterior cells with EnGal4 (right side of dotted
line in F). (F) dmyc mRNA is increased in posterior
cells in response to UAS-yki expression.
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within intron 2 (In2) (Figure 3). The promoter-proximal sites and
a cluster of three sites within In2mapped near three independent
P-element insertions that report lacZ expression from the dm
locus (Bourbon et al., 2002; Peter et al., 2002). Each of these
P-lacZ insertions responded robustly to UAS-yki by increasing
lacZ expression, supporting the idea that regulatory regions in
their vicinity are under transcriptional control by Hpo signaling
(Figures 3D–3G; Figures S3A and S3B).
Next, we carried out chromatin immunoprecipitation (chIP)
experiments on the dm locus with chromatin isolated from
wild-type imaginal discs. We designed primers to amplify
regions of the dm locus that covered all of the potential Sd510 Developmental Cell 19, 507–520, October 19, 2010 ª2010 Elsevier Inc.binding sites as well as the insertion
regions of each P-element reporter.
DNA amplified from chromatin precipi-
tated with antibodies against Yki was
specifically and significantly enriched in
the region that harbors the two pro-
moter-proximal P-element insertions
(Figure 3H, amplicon B). This region
includes two putative Sd sites that are
fairly divergent from the consensus
CATTCC sequence, whereas an up-
stream perfect match to the consensus
Sd site was not enriched (Figure 3H, am-
plicon A). In addition two amplicons
within In2 showed enrichment above
background in four independent experi-
ments, although the combined average
was not significant (p = 0.07; Figure 3H,
amplicons C and D). These amplicons
include the intronic cluster of three Sd
consensus sites. An amplicon covering
an additional single consensus Sd sitejust downstream was never enriched in the experiments, nor
was an internal negative control region in the first coding exon
(Figure 3I). None of the regions was enriched when precipitated
with control IgG antiserum, and a region in the pyruvate dehydro-
genase (PD) gene, which served as a negative control, was not
enriched in the Yki-precipitated chromatin, confirming the spec-
ificity of the reactions (Figures 3H and 3I). Our results demon-
strate that specific binding of endogenous Yki protein occurs
at the dm promoter (Pr) region and in In2 in growing wild-type
discs (Figure 3H).
We then examined whether Sd bound to these regions of the
locus. We used a protein trap line in which an in-frame insertion
of GFP is spliced into Sd coding exons, producing a GFP-Sd
Figure 3. dMyc Is a Transcriptional Target of the Hpo Pathway
(A)Wing disc expressingUAS-GFP, UAS-dcr-2 and aUAS- shsd under DppGal4 control (green). Reduction of sd expression reduces dMyc expression in thewing
pouch (arrow, A0 ), but Nub expression is generally unaffected (A00).
(B) Clones expressing UAS-GFP (B00) and UAS-yki upregulate dMyc (magenta) in the wing pouch and ectopically activate dMyc in proximal cells (arrow in B0 and
B00). Arrowhead points to a clone at the D-V boundary that does not alter dMyc expression.
(C) GFP-marked clones expressing UAS-yki, UAS-shsd, and UAS-dcr-2. Reduced Sd expression prevents dMyc upregulation (magenta) in its endogenous
domain and ectopic activation in proximal cells (arrow in C0 and C00).
(D and E) Beta-galactosidase (b-gal) expression (magenta) from a P-element insertion (G0359) into the proximal promoter region of the dm locus. See also
Figure S3. (D–D00) Control wing disc. (E–E00) Wing disc expressing UAS-yki in clones. G0359-lacZ responds strongly to UAS-yki expression. GFP marked clones
are shown in (E00).
(F) b-gal expression from a P-element insertion (PL35) into In2 of the dm locus.
(G) Expression of Yki under Engal4 control leads to strong upregulation of b-gal (magenta).
(H–J) Schematic representation of the dm locus. Black rectangles are coding regions, white rectangles are noncoding regions; lines denote introns. Red bars
indicate consensus Sd binding sites, and green lines are degenerate Sd binding sites in the locus; red triangles represent Yki-responsive P-element insertions.
Blocks labeled A–F represent regions amplified in the chIP experiments. (H) Yki chIP on the dm locus. Anti-Yki (Yki IP) or IgG (mock IP) antibodies were used to
precipitate chromatin from wt discs; quantitative RT-PCR was done on regions A–D and on a negative control locus, PD. Graph shows the enrichment of signal
over input for A–D and PD. Amplicons B–D were all consistently enriched over PD in each of four independent experiments, although statistical significance was
obtained only for amplicon B, due to noise between experiments. (I) chIP data covering amplicon E, in the first coding exon (a negative control) and amplicon F,
covering a single Sd site. Neither amplicon was enriched relative to PD in the experiments. (J) Sd-GFP chIP on the dm locus. Amplicons B–D showed significant
enrichment after precipitation of wt disc chromatin with antibodies against GFP. The strongest enrichment occurred of amplicon D, where a cluster of three highly
conserved Sd sites is located (data not shown; www.modencode.org). Inset shows expression from Sd-GFP line. p values, **p < 0.01.
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Figure 4. Codependency of dMyc and Yki in Growth Regulation
(A–I) MARCM TubGal4 > UAS-GFP clones (green) that express UAS-dmyc (alone or together with other transgenes) in yki mutant clones; their wt CD2 sibling
clones are magenta. (A) Discs with control clones. (B) Clones expressing UAS-dmyc. (C) Clones expressing UAS-yki. (D) ykiB5 mutant clones. (E) ykiB5 mutant
clones rescued by yki expression. (F) ykiB5 mutant clones that express UAS-dmyc. (G) ykiB5 mutant clones that express UAS-diap1*. (H) ykiB5 mutant clones
that coexpress UAS-dmyc and UAS-diap1*. (I) ykiB5 mutant clones that coexpress UAS-dmyc and UAS-bantam.
(J) Clone size quantification. UAS-diap1* or UAS-bantam expression slightly rescues growth of ykiB5 clones. UAS-dmyc significantly increases size of wt clones
but fails to increase ykiB5 mutant clone size, even with coexpression of UAS-diap1* or UAS-bantam.
(K–N) Fibrillarin staining in wing imaginal discs with clones expressing dmyc (K); with ykiB5 mutant clones expressing dmyc (L); with clones expressing dmyc +
bantam (M); and with ykiB5mutant clones expressing UAS-dmyc + UAS-bantam (N). UAS-dmyc upregulates Fibrillarin and increases nucleolar size in wt cells (K)
and in ykiB5mutant cells (L and N), indicating that some growth-promoting targets of dMyc are independent of Yki. Green lines in (K–N) indicate clone boundaries.
See also Figure S4. P value, ***p < 0.001. ns, not significant.
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This protein trap line is homozygous viable and allowed us to
use anti-GFP antibodies to pull down Sd in chIP experiments
because antibodies against Sd were unavailable. We found
that the enriched sequences of the dm locus from disc chromatin
immunoprecipitated by anti-GFP were identical to those that
bind Yki (Figure 3J), suggesting that these two factors might
coassociate on the DNA in vivo. Interestingly, the In2 region
was most highly enriched in the experiments using anti-GFP
antibodies, correlating well with the fact that the cluster of Sd
sites there is conserved among several Drosophila species
(Figure 3J and data not shown). Thus, our results demonstrate
that endogenous Yki and Sd protein bind to the same DNA512 Developmental Cell 19, 507–520, October 19, 2010 ª2010 Elsevsequences at the dm locus. Along with the Yki-induced tran-
scriptional activation of Plac-Z reporter insertions in these
regions, the specific binding of Yki and Sd to these sites
suggests a mechanism by which dMyc expression could be
physiologically regulated by the Hpo pathway.
dMyc and Yki Cooperate in Growth Regulation
Yki is required for cell proliferation (Figures 1G and 4D) in part
because its loss in cells prevents expression of diap1 and
bantam, targets of Yki that promote cell survival (Nolo et al.,
2006; Thompson and Cohen, 2006; Wu et al., 2003). Expression
of UAS-diap1 or UAS-bantam in ykiB5 mutant clones can
increase clone size to a limited extent (Figures 4G–4J) (Noloier Inc.
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indicated that dMyc is a transcriptional target of Yki and is
required for UAS-yki to promote growth, we asked whether
dMyc expression would promote the growth of yki mutant cell
clones. We expressed UAS-dmyc in ykiB5 mutant cell clones
by itself, or with UAS-bantam or an activated form of diap1
(UAS-diap1*) to increase cell survival, and analyzed clone size
after a defined growth period. Expression of UAS-dmyc either
alone (Figure 4F), with UAS-diap1* (Figure 4H), or with UAS-
bantam (Figure 4I) was unable to rescue the growth defect of
yki mutant clones. In fact ykiB5 clones that coexpressed UAS-
dmyc and UAS-diap1* or UAS-bantam grew to a similar size as
those expressing either survival factor alone (Figure 4J). The
size of ykiB5 clones was also not rescued when UAS-dmyc was
expressed in anterior cells with CiGal4, indicating that the lack
of clonal growth was not an effect of Gal80 perdurance in the
MARCMexperiments (data not shown). These results suggested
the possibility that dMyc’s ability to drive growth in yki mutant
cells could be compromised.
Control of ribosome biogenesis is central to Myc’s growth-
promoting function (Grandori et al., 2005; Grewal et al., 2005),
andmisexpression of dMyc activates expression of the nucleolar
protein Fibrillarin and increases nucleolar and cell size (Figure
S4B) (Grandori et al., 2005; Grewal et al., 2005). These features
are unique to dMyc because expression of the Yki target bantam
did not lead to these changes (Figure S4C). To determine
whether UAS-dmyc expression still enhanced ribosome biogen-
esis and cellular growth in cells lacking yki, we generated ykiB5
clones and coexpressed bantam to promote survival of the cells.
Despite the small size of the clones (Figures 4J–4N), cell size,
nucleolar size, and Fibrillarin expression were increased when
UAS-dmyc, with or without UAS-bantam, was expressed in
ykiB5 mutant cells (Figures 4L and 4N and data not shown).
This clearly shows that dMyc’s ability to promote ribosome
biogenesis is unimpaired in ykimutant cells but that cells lacking
yki fail to respond growth-promoting inputs from dMyc in
a manner that specifically allows tissue expansion. Collectively,
these results suggest that dMyc and Yki induce nonredundant
targets and that for appropriate tissue growth the coordinated
function of both factors is required.
Yki Expression Is Regulated by dMyc through Multiple
Mechanisms
To investigate how the activities of Yki and dMyc are integrated
during tissue growth, we examined whether Hpo activity itself
was subject to control by dMyc. We tested this idea by exam-
ining the expression, subcellular localization, and activity of Yki
in cells in which dmyc was either reduced or augmented. dMyc
expression was eliminated by generating dm4 null mutant cell
clones or reduced by expression of UAS-dmyc shRNA in flp-out
Gal4 clones. Strikingly, complete or partial loss of dmyc visibly
increased the overall level of Yki protein within clones located
in the wing pouch (Figures 5B and 5D). Interestingly, the increase
in Yki levels did not alter its subcellular localization (Figure 6C00,
arrow). Conversely, Yki expression was markedly reduced in
cells of flp-out Gal4 clones in which UAS-dmyc was expressed
(Figure 5G). Yki expression was unchanged in control clones
(Figures 5A and 5C). Control of Yki expression in cells with
high or low dMyc was cell autonomous because it also occurredDevelopmwhen dMyc expression was manipulated in whole compart-
ments (Figures 5E and 5F). The inhibitory effect of dMyc on Yki
expression was specific because expression of the well-charac-
terized growth regulators cyclin D + Cdk4, its dedicated cyclin-
dependent kinase, or the catalytic subunit of the PI3K, Dp110,
did not alter Yki expression (Figures S5A–S5C) (Datar et al.,
2000; de la Cova et al., 2004; Leevers et al., 1996). The increase
in Yki upon the loss of dMyc was restricted to the wing pouch,
where dMyc is normally present at high levels (Figures 5F,
arrows, and 2A0). Because Yki expression in wild-type discs is
fairly uniform (Figure 5C0), the specificity of this increase
suggests that the endogenous pattern of dMyc expression has
a role in keeping Yki expression uniform across the disc.
Quantitative polymerase chain reaction (Q-PCR) experiments
showed that dMyc-expressing cells had approximately 30%
less yki mRNA than controls, suggesting that the reduction in
Yki expression by high dMyc is partially under transcriptional
control (Figure S3C). To test for posttranscriptional regulation
of Yki by dMyc, we used the ykiB5 null allele to eliminate endog-
enous yki expression but provided it through a transgene driven
by the tubulin promoter (Tub-yki), which rescues the homozy-
gous mutants to viability (Huang et al., 2005). In ykiB5animals
carrying Tub-yki, all Yki protein is expressed from the rescuing
transgene and is, thus, not subject to transcriptional control by
dMyc. Under these conditions Yki protein was still strongly
decreased in cells with high dMyc (Figures 5H and 5H0), indi-
cating that much of the regulation of Yki by dMyc occurs via
a posttranscriptional mechanism. These results demonstrate
that dMyc’s regulation of Yki occurs though both transcriptional
and posttranscriptional mechanisms and suggest that the rela-
tive level of dMyc in a cell regulates the cellular quantity of Yki.
Negative Feedback from dMyc Controls Yki Activity
Our experiments suggest that a circuit of negative feedback
exists between dMyc and Yki, such that expression of dMyc is
dependent upon Yki activity. In turn cellular Yki levels are influ-
enced by the quantity of dMyc within a cell. Yki activity requires
nuclear localization (Huang et al., 2005) but should also be
affected by its overall level in the cell. If so, changes in Yki
expression should have functional consequences by influencing
expression of its target genes. This view is supported by the
observation that the Sd-dependent transcriptional response in
the wing disc is sensitive to the dose of Yki (Goulev et al.,
2008). To test this idea we expressed UAS-dmyc in flp-out
Gal4 clones to reduce Yki levels and examined the expression
of Yki target genes in those cells. As predicted, expression of
three Yki targets—diap1, expanded (ex), and four-jointed (fj)—
was significantly decreased in UAS-dmyc-expressing cell clones
(Figures 5I–5L). The activity of transcriptional reporters of each
gene also dropped sharply in response to UAS-dmyc expres-
sion, demonstrating that transcription of each target was
reduced (Figures 5J and 5L and data not shown). Therefore,
high levels of dMyc that reduce Yki expression also diminish
the transcriptional activity of Yki on its target genes.
Because high dMyc reduces Yki target gene expression, it
might be expected that reducing dMyc levels would upregulate
Yki targets. However, this was not the case: cells with reduced
dMyc did not show obvious changes in Yki target gene expres-
sion (data not shown). Because previous work suggested thatental Cell 19, 507–520, October 19, 2010 ª2010 Elsevier Inc. 513
Figure 5. dMyc Regulates Yki Expression and Activity
(A–H) Yki immunostaining (magenta) in wing discs. (A and A0) Control wing disc clones and (B and B0) dm4 mutant clones. Clones are marked by the absence of
green (arm-lacZ, dotted line indicates clone boundaries). (B0) Highmagnification of area boxed in (B). dm4 clones have elevated Yki expression (arrows). (C and D)
Control ActGal4 > UAS-GFP clones (green) (C and C0) or clones expressing UAS-shdmyc (D and D0). (D0) A higher magnification of area boxed in (D). Moderate
reduction of dMyc is sufficient to increase Yki protein (arrows). (E and E0) Wing discs expressing UAS-dmyc (E and E0) or UAS-shdmyc (F and F0) in posterior cells
(green) under EnGal4 control. Yki expression is decreased in high dMyc cells throughout the disc and increased in low dMyc cells within the wing pouch (upper
and lower boundaries are marked by arrows in F0). See also Figure S5. (G and G0) Clones expressing dmyc, marked with UAS-GFP expression (green). Yki is
decreased in clones expressing dmyc (arrow). (H and H0) Clones expressing dmyc in a ykiB5 animal rescued with a Tub-yki transgene. All Yki expression is
from the transgene. UAS-dmyc represses Tub-yki in the clones (arrows), indicating that dMyc also regulates Yki expression posttranscriptionally. dmyc expres-
sion also reduces yki mRNA 30% below wild-type levels (see Figure S3).
(I–L) Expression of Yki targets is diminished by UAS-dmyc expression. dIAP1 protein (I), expanded-lacZ (J and J0), Four Jointed (K and K0), and fj-lacZ (L and L0 ) are
all downregulated (arrows) in clones expressing UAS-dmyc.
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Figure 6. Wild-Type Levels of dMyc Regulate Yki
(A) Wing disc with wtsx1mutant clones immunostained for Yki (red). (A0) Close-up view of the region boxed in (A). wtsx1 mutant cells are marked by absence of
b-gal. (A00) Yki expression. In thewtsmutant clone, Yki is somewhat diffuse, with both nuclear and cytoplasmic localization. (A00 0) Close-up of merged channels of
box in (A).
(B) Yki staining (red) in wing disc withwtsmutant clones and expressing UAS-shdmyc in posterior cells under EnGal4 control. (B0)wtsmutant cells are marked by
lack of b-gal. Posterior cells are located to the right of the dashed yellow line (B0 and B00) and show reduced levels of dMyc (B00 0). Box A is located in the anterior
compartment and box P in the posterior.
(C) Close-up view of the region inside box P. The red dotted linemarks thewtsx1clone boundary, mutant cells lack b-gal. Cells to the right of the yellow dashed line
express UAS-shdmyc; the arrow points to nonmutant tissue (b-gal-positive). Note the substantial accumulation of Yki in the nucleus of wtsx1 cells that have
reduced dMyc levels due to expression of UAS-shdmyc.
(D) Close-up view of the region inside box A.wtsx1mutant clone (red line in D located in the anterior compartment ismarked by the absence of b-gal) (D0). As in (A00),
Yki staining is more diffuse, with some nuclear localization (D00 and D00 0), but substantially less than in wtsx1 clones located in the posterior compartment, which
express lower levels of dMyc (compare to C00 and D00).
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nuclear localization by Wts (Dong et al., 2007), the increased Yki
in cells with low dMyc levels might not have reached this
threshold. Consistent with this idea, we were unable to clearly
detect nuclear Yki in the cells with reduced dMyc. This led us
to consider the possibility that, in wild-type cells, endogenous
Yki is constrained by limits on its cellular accumulation (e.g.,
by dMyc) as well as by its subcellular localization (e.g., byDevelopmWts). This type of mechanism could help to explain why in
wtsx1 mutant cells, the distribution of Yki is both nuclear (tran-
scriptionally active) and cytosolic (transcriptionally inactive)
(Dong et al., 2007). Based on this idea, we hypothesized that
nuclear, active Yki upregulates dMyc, which then decreases
Yki levels, thereby reducing the amount of Yki available for
nuclear localization. A prediction of this hypothesis is that if
the negative input on Yki from endogenous dMyc was relaxed,ental Cell 19, 507–520, October 19, 2010 ª2010 Elsevier Inc. 515
Figure 7. A Model for a Homeostatic Feedback Mechanism That Prevents Runaway Growth
(A) Size of Act > Gal4 cell clones expressing UAS-GFP, UAS-dmyc, UAS-yki, or coexpressing UAS-yki and UAS-dmyc. Simultaneous expression of Yki and dMyc
drives significantly more growth than expression of either factor alone. ***p < 0.001.
(B and C) Cell death, assessed by TUNEL staining (red), in wing discs with wild-type (B) orwtsx1mutant clones (C), where UAS-dmycwas expressed in the poste-
rior compartment.wtsx1 cells are marked by absence of b-gal (green), and the posterior compartment is marked by absence of Ci, a marker of anterior cells (blue).
wtsx1 mutant tissue is protected from cell death induced by deregulated dMyc (arrows).
(D–F) A model of codependent regulation between Yki and dMyc. In wt cells (D), nuclear (active) Yki activates expression of dmyc and other Hpo target genes
(diap1, bantam, fj). Negative feedback between dMyc activity and Yki expression keeps the activity of each in balance. (E) In wts mutant cells, Hpo signaling is
inactivated; more active Yki increases dMyc expression. High dMyc expression and activity will decrease Yki expression, which in turn will curb dMyc expression,
resetting a balance and limiting overgrowth. (F) Cells expressing deregulated levels of dMyc will decrease Yki expression, resulting in loss of Yki pro-survival
targets and cell death. In the model, deregulation of both dMyc and Yki expression will abolish the negative feedback loop and promote overgrowth; in mammals
this could lead to cancer.
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this we decreased dMyc levels in posterior cells by expressing
UAS-shdmyc with EnGal4, while at the same time relieving
a cytosolic constraint on Yki by making clones of wtsx1 mutant
cells. wtsx1 mutant clones were generated throughout the
disc, allowing the anterior clones to provide an internal control
for the behavior of Yki in wtsx1 cells with wild-type dMyc levels.
The anterior wtsx1 mutant cells possessed both cytosolic and
nuclear Yki, and the clones contained an average of only 8.5%
of nuclei with complete or near-complete nuclear Yki staining
(±6.3, n = 5; Figures 6B and 6D). Posterior cells with wild-type
Wts had increased Yki expression due to the reduced dMyc
expression, but it was primarily cytosolic (Figures 6C0 and 6C00,
arrows). In striking contrast 47.8% (±6.5, n = 5) of posterior,
UAS-shdmyc-expressing cells that were also wtsx1 mutant had
nuclear Yki staining that completely covered the nucleus
(Figures 6B and 6C). Together, these results provide compelling
evidence that, at wild-type levels, dMyc functions to limit Yki
expression and thereby restrains its subcellular location. These
data are consistent with the idea that the cellular level of dMyc
contributes to regulation of Yki activity.516 Developmental Cell 19, 507–520, October 19, 2010 ª2010 ElsevA Model for Stabilization of Tissue Growth through
Feedback between dMyc and Yki
Based on our results, we propose the following model of how the
growth-promoting properties of dMyc and Yki are integrated to
stabilize growth (Figure 7D). Under normal growth conditions,
Hpo activity is relatively low, allowing a pool of nuclear, active
Yki to promote expression of target genes that regulate cell
survival and growth, including dMyc. The accumulation of
dMyc in the cell represses Yki expression, thereby setting a limit
on howmuch Yki is able to translocate into the nucleus and acti-
vate target genes. This classic negative feedback relationship
would calibrate the expression of each factor and, hence, their
respective growth-promoting activities, and at the same time
integrate the output of the two pathways. Tissue growth would
be promoted while at the same time kept in check; thus, the
mechanism is potentially homeostatic (Figure 7D).
Because inactivating theHpopathway or overexpression of Yki
leads to growth that is greater than normal (e.g., Figures 2A–2C),
our model predicts that this growth would still be limited by nega-
tive feedback fromendogenous dMyc (Figure 7E). However, elim-
inating the feedback loop between dMyc and Yki should preventier Inc.
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promote growth independently, thereby greatly enhancing the
extent of growth. We tested this idea by comparing the extent of
growth induced by heterologous expression of dMyc, Yki, or
both, under Gal4 control. These conditions should override both
the constraints from theHpopathwayand someof those imposed
by dMyc. Even though dMyc’s posttranscriptional control of Yki
would not be prevented, this should be offset by the continuous
expression of each factor under Gal4 control. The results of this
experiment show that during the same growth period, the growth
of clones of cells expressing both UAS-dmyc and UAS-yki was
enhanced and grew significantly larger than clones expressing
either factor alone (Figure 7A).
A second prediction arising from our model follows from the
observation that high dMyc cells have reduced expression of
Yki target genes. Thus, lowered expression of Yki’s effector of
cell survival, dIAP1, should result in increased apoptosis of cells
expressing high levels of dMyc. We tested this by expressing
dMyc in posterior wing disc cells under EnGal4 control and
resupplying Yki activity in some cells by making wtsx1 mutant
clones in this background. As observed previously, expression
of UAS-dmyc induced apoptosis in many posterior cells of these
discs (Figure 7B) (de la Cova et al., 2004; Montero et al., 2008).
However, in this background the resulting increase in Yki activity
and, consequently, in dIAP1 expression in wts mutant clones
(Huang et al., 2005; Nolo et al., 2006; Thompson and Cohen,
2006; Wu et al., 2003) attenuated the effect of high dMyc, so
that the clones formed islands of cells protected from death
(Figure 7C). Thus, although deregulated high-level expression
of dMyc has the potential to fuel aberrant growth, its feedback
regulation of Yki expression provides a contingency mechanism
that prevents the cells from surviving. These data provide
evidence that endogenous dMyc expression provides a critical
layer of regulation of Yki activity. Taken as a whole, our data
suggest that the relationship between dMyc and Yki integrates
and coordinates the activities of both and provides amechanism
that sets limits on tissue growth.
DISCUSSION
The data we have presented here provide evidence for a mecha-
nism that integrates the expression and functions of two well-
conserved gene regulatory factors—dMyc and Yki—that play
critical roles in Drosophila organ size control. In a mouse hepatic
carcinoma cancer model induced by overexpression of the Yki
homolog Yap, c-Myc was upregulated in microarray experi-
ments, but the functional relationship between Yap and cMyc
was not explored (Dong et al., 2007). Our results demonstrated
that Yki regulates expression of dMyc and also requires dMyc
to drive growth. In addition we showed that endogenous Yki
directly binds specific DNA sequences in the Drosophila myc
gene, dm, and we identified three P-element insertions into the
locus in the vicinity of these binding sites that respond robustly
to Yki expression, suggesting that Yki might directly transcrip-
tionally activate expression of dMyc. In addition our data showed
that the Yki-associating DNA binding partner, Sd, binds to the
dm locus at the same regions occupied by Yki and is required
for dMyc expression in the wing disc. These data provide strong
suggestive evidence that Yki/Sd transcriptional complexes regu-Developmlate the activity of the dm downstream of Hpo signaling.
However, our results do not rule out the possibility that additional
transcription factors participate in dm regulation by Yki. In eye
discs, Yki associates with the Hox cofactor Hth to regulate the
bantam locus (Peng et al., 2009). We think it unlikely that Hth
functions with Yki to transactivate dMyc because the loss of
hth does not affect dMyc expression (data not shown). Still,
Yap and its paralog, Taz, utilize numerous transcription factors
as transcriptional coactivators (Wang et al., 2009), and it is quite
plausible that this is true for Yki as well. Given the significant
evolutionary conservation of both Myc and the Hpo pathway
functions, the relationship we uncovered here may be an impor-
tant regulatory mechanism of growth in many animals.
Feedback between dMyc and Yki Promotes Stable
Growth during Wing Development
A key finding of our study is that in addition to its role as a Yki
target gene and growth effector, dMyc exerts control over
Yki expression. This provides Yki with another layer of regulation
over its well-described regulation by subcellular localization.
Interestingly, our experiments demonstrate that dMyc’s regula-
tion of Yki occurs through both transcriptional and posttranscrip-
tional mechanisms. By regulating Yki, dMyc indirectly regulates
its own expression and that of other Hpo pathway targets and,
thus, balances its growth-promoting function with the growth-
suppressing function of the Hpo pathway.
Our experiments demonstrated that when under Gal4 control,
co-overexpression of dMyc and Yki causes significantly more
growth than either factor alone. On its own this result is consis-
tent with the interpretation that these two growth-promoting
factors are independent and function in parallel to enhance
growth when coexpressed. Indeed, each regulator does appear
to carry out independent functions. For example overexpression
of dMyc increases cell size and nucleolar size in a manner that
does not depend upon Yki. Whereas Yki promotes ‘‘balanced
growth,’’ in which cells divide at the same rate as they increase
in mass, yielding cells of normal size (Huang et al., 2005; Panta-
lacci et al., 2003; Tapon et al., 2002), growth promoted by dMyc
is ‘‘unbalanced’’: it promotes cellular growth by enhancing ribo-
some biogenesis but is unable to promote cell division in the
wing disc, resulting in large cells with large nucleoli (Johnston
et al., 1999). However, our results also indicate that the activities
of dMyc and Yki are not completely independent. dMyc is
positively regulated by Yki and, thus, is dependent upon Yki for
its expression, and Yki expression is negatively regulated by
and, therefore, dependent upon dMyc. These data provide
evidence for a codependent relationship between dMyc and
Yki that integrates their expression and function. Therefore, we
favor the interpretation that the additional growth driven by the
combined overexpression of dMyc and Yki occurs because
continuous Gal4-driven expression of both factors bypasses
Wts regulation and dampens dMyc’s ability to repress Yki
expression, thereby allowing the potent growth-promoting prop-
erties of both factors to prevail (Figures 7D and 7E).
Implications of the Regulatory Relationship between
dMyc and Yki
Does this regulatory relationship between dMyc and Yki have
functional consequences for growth? We suggest that it does.ental Cell 19, 507–520, October 19, 2010 ª2010 Elsevier Inc. 517
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sion would limit the expression and activities of both and thereby
could limit the overall growth of the tissue. It could also ensure
the death of cells with deregulated Myc activity, and as a result
prevent expansion of cells with dangerously high growth poten-
tial. Indeed, negative feedback on Yki from dMyc provides an
explanation for Myc’s well-known propensity for sensitizing cells
to apoptosis when it is highly expressed (de la Cova et al., 2004;
Montero et al., 2008; Pelengaris et al., 2002).
Our experiments suggest that the dMyc-Yki regulatory
relationship is important for regulating the extent of tissue growth
during the disc growth period. However, complete abrogation of
the negative feedback loop is not possible without an under-
standing of the posttranscriptional mechanism by which dMyc
controls Yki. Yki is anchored in the cytoplasm via phosphoryla-
tion by the Wts kinase and 14-3-3 binding (Huang et al., 2005)
and also through direct binding of various Hpo pathway
members by phosphorylation-independent processes (Badouel
et al., 2009b; Oh et al., 2009). Both of thesemechanisms prevent
its nuclear localization and activity. Interestingly, the stability of
Yap1 is regulated by interactions with b-TRCP, a component
of the SCF E3 ubiquitin ligase complex, in cultured mammalian
cells. However, the relevant phosphodegron is not conserved
in Yki (Zhao et al., 2010), suggesting that other mechanisms
underlie posttranscriptional control of Yki by dMyc. Neverthe-
less, other observations may shed light on how the regulatory
relationship between dMyc and Yki affects organ growth. For
example loss of dmyc by mitotic recombination is generally
lethal to cells due to the block to cellular growth and to cell
competition (Johnston et al., 1999). However, loss of dmyc
from all cells of thewing discmidway through larval development
allows the formation of adult wings, albeit rudimentary in size
(Wu and Johnston, 2010). This might be explained by our
finding that dMyc negatively regulates Yki expression and
activity: because competition between cells is eliminated and
Yki is no longer subject to negative regulation by dMyc, a limited
amount of growth may be possible because of increased cell
survival and a few cell divisions. Increased negative feedback
from dMyc to Yki may also explain the observation that adult
wings are only 15% larger when dMyc is expressed at 70%
over wild-type levels under heterologous control, much less
than expected given the high level of dMyc expression
(Wu and Johnston, 2010). Conversely, loss of Yki-regulated tran-
scription of dMyc could affect their functional coordination and
reduce the overall growth rate; consistent with this possibility,
constitutive expression of dmyc at 80% of wild-type levels in
an otherwise null dmycmutant slows wing disc growth and leads
to adult wings that are 33% smaller than wild-type (Wu and
Johnston, 2010).
Although dMyc receives input from the disc patterning system,
evidence suggests it is indirect (Herranz et al., 2008; Johnston
et al., 1999; Wu and Johnston, 2010). Yki’s control of dMyc
expression effectively couples the patterning system to regula-
tion of dMyc because the Hpo pathway is controlled by Dpp,
a major organizer of pattern in the wing disc (Rogulja et al.,
2008). In addition Yki has a role in propagating expression of
the wing selector gene, vestigial (vg), which drives expansion
of the presumptive wing region of the wing disc (Zecca and
Struhl, 2010). Early in wing disc development, dMyc is expressed518 Developmental Cell 19, 507–520, October 19, 2010 ª2010 Elsevin all cells, whereas Vg expression is restricted to cells at the
dorsal-ventral boundary. This raises the possibility that Yki’s
regulation of dMyc expression provides fuel for the proliferation
of cells that are recruited by Vg to form thewing blade.Moreover,
as later dMyc expression becomes similar to Vg, dMyc could
also provide restraint to the recruitment process through its
feedback on Yki expression.
We propose that positive regulation of dMyc by Yki and nega-
tive feedback from dMyc to Yki moderates the powerful growth
stimulatory input to cells and, thus, generate an inherently stable
system of growth in the developing tissue. In addition because
our experiments demonstrated that changes in Hpo signaling
activity locally induce cell competition that specifically mimics
competition induced by differences in dMyc, dMyc appears to
contribute to organ homeostasis both cell autonomously, as an
effector and regulator of Yki, and noncell autonomously, as
a mediator of cell competition provoked by local changes in
the Hpo pathway.
Deregulation of the Negative Feedback between Myc
and Yap: A Tumor Accelerant?
Myc is a widely conserved transcriptional regulator that controls
many aspects of cell biology, and its deregulation is a key medi-
ator of numerous cancers. Several mammalian components of
the Hpo pathway are also linked to cancer, including Mst1/2/
Hpo, WW45/Sav, Lats/Wts, Mats, and Yap/Yki (reviewed in
Pan, 2007 and Reddy and Irvine, 2008). Amplification of human
chromosome 11q22, which contains the Yap and cIAP genes,
is observed in glioblastomas and in pancreatic, ovarian, cervical,
and lung cancers (Overholtzer et al., 2006). Oncogenomic
approaches in mouse transgenic models of breast and liver
cancers identified Yap, either alone or in combination with
cIAP1, as a tumor accelerant that can synergize with c-Myc
deregulation (Zender et al., 2006). This is a striking parallel to
our finding that coexpression of Yki and dMyc significantly
enhances clonal growth over that stimulated by Yki or dMyc
alone and suggests broad implications of our findings. Our
model of feedback between two growth regulators also raises
the possibility that amplification and the contingent deregulation
of Yap are positively selected in nascent tumors to circumvent
normal regulation between Yap and Myc. Therefore, an impor-
tant future challenge is the elucidation of the interactions
between these pathways in humans and their potential impact
in organ and tissue size control and tumorigenesis.
EXPERIMENTAL PROCEDURES
Generation of Clones and Clone Size Measurements
The Gal4/UAS system was used for misexpression of transgenes (Brand and
Perrimon, 1993). Clonal overexpression was achieved using Flp-out Gal4
(Act > y+ > Gal4; (Pignoni and Zipursky, 1997)) and MARCM (Lee and Luo,
1999). Mutant clones were generated by Flp/FRT-mediated mitotic recombi-
nation (Xu and Rubin, 1993). Heat shocks were given at 48 ± 3 hr AEL and
animals dissected for analysis in late-third instar (typically between 98 and
110 hr AEL under our laboratory conditions). MARCM was used to express
transgenes inmitotic clones; TubGal4 was used to drive transgene expression,
except for the dm4; UAS-yki experiment (Figure 1), where T80Gal4 was used.
Heat shocks were given at 30 ± 2 hr AEL, and animals were dissected at 116 ±
2 hr AEL. Cell competition was evaluated with MARCM as previously
described (de la Cova et al., 2004). Heat shocks were given at 30 ± 2 hr AEL
and animals dissected for analysis at 110 ± 2 hr AEL. In all cases clone sizeier Inc.
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the marked clones using Axiovision software (Zeiss). Twenty clones or more
were examined for each experiment. Two-tailed Student’s t tests with unequal
variance were used to determine significance. The percentage of nuclear Yki
staining in wtsx1 mutant clones in the presence or absence of WT dMyc was
calculated as the percentage of cells per anterior clone (control) or posterior
clone (expressing UAS-shdmyc) that expressed Yki protein with complete or
nearly complete (>3/4 nucleus) overlap with the DNA stain (Hoechst).
Immunocytochemistry
Fixation and immunocytochemistry of imaginal discs were carried out as
described (Johnston and Edgar, 1998). RNA in situ hybridizations were carried
out using digoxigenin-labeled RNA probes (Johnston and Edgar, 1998).
Images were acquired using Apotome software and a Zeiss Axioplan 2 micro-
scope with an Orca-100 CCD camera (Hammatsu) and processed with
Photoshop (Adobe) software. Antibodies used were (dilutions and sources in
parentheses): guinea-pig anti-dMyc (1:1000, G. Morata); mouse anti-Nubbin
(1:100, DSHB); mouse anti-CD2 (1:400, Serotec); rabbit anti-b-galactosidase
(1:2000, Cappel); mouse anti-Fibrillarin (1:500, John Aris); rabbit anti-Yki
(1:500, D. J. Pan); mouse anti-DIAP1 (1:200, B. Hay); rat anti-Four-Jointed
(1:1000, D. Strutt); Rat anti-Ci (1:25, R. Holmgren); anti-mouse Cy3 (1:600,
Jackson Laboratories); anti-rat Cy3 (1:600, Jackson Laboratories); and anti-
rabbit AlexaFluor488 (1:600, Molecular Probes). TUNEL assays were carried
out using Apoptag Red (Chemicon International) (Wells et al., 2006).
Chromatin Immunoprecipitation
chIP assays were based on a previously described protocol (Estella et al.,
2008) on wild-type wing, haltere, and third leg discs. Mid-third instar (98 hr
AEL) yw; +; + larvae were dissected in cold PBS and fixed for 25 min at
room temperature in 1.8% formaldehyde, 50 mM HEPES, 1 mM EDTA,
0.5 mM EGTA, and 100 mM NaCl. Twenty animals were processed at
a time, and a total of approximately 120 animals were dissected. After quench-
ing (0.125 M Glycine, 13 PBS, 0.01% Triton), the tissue was washed twice in
Buffer A (10 mM HEPES, 10 mM EDTA, 0.5 mM EGTA, 0.25% Triton, 1 mM
PMSF, plus complete protease inhibitor cocktail [Roche]), then twice in Buffer
B (10 mM HEPES, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.01% Triton,
1 mM PMSF, plus complete protease inhibitor cocktail [Roche]), for 10 min
at 4C. Wing, third leg, and haltere imaginal discs were then dissected from
larval cuticle in Buffer B. Discs were sonicated in Buffer C (10 mM HEPES,
1 mM EDTA, 0.5 mM EGTA, 1 mM PMSF, plus complete protease inhibitor
cocktail [Roche]) on ice. Soluble chromatin was transferred to a new tube after
centrifugation, and 10% was removed for Input. Fresh chromatin, precleared
with protein A/G agarose beads (Santa Cruz), was incubated overnight at 4C
with antibodies in RIPA buffer (140 mMNaCl, 10 mMHEPES, 1 mM EDTA, 1%
Glycerol, 1% Triton X-100, 0.1% DOC, and 1 mM). Antibody-chromatin
complexes were pulled down with protein A/G agarose beads for 3 hr at
4C. Beads were then washed four times in RIPA buffer and once in TE. Chro-
matin was eluted twice in Elution Buffer (1% SDS, 0.1 M NaHCO3). To reverse
crosslinks, eluted material was incubated at 65C overnight. Twenty micro-
grams Proteinase K was added, and samples were incubated for 3 hr at
55C. Phenol-chloroform extraction and ethanol precipitation were used to
clean up DNA. Real-time PCR analysis was performed on an ABI 7300 instru-
ment using SYBR Green PCR Master Mix (Applied Biosystems) per manufac-
turer’s instructions. Results were quantified using the delta Ct method, with
respect to input samples. Rabbit anti-Yki (D.J. Pan) was used at a final concen-
tration of 1:300 and rabbit anti-GFP used at 1:300 (Ab-Cam); specificity was
evaluated by immunoprecipitations performed in parallel with normal rabbit
IgG (Santa Cruz). Primer sequences are available on request.
Quantitative RT-PCR
RNA was isolated from wing, haltere, and third leg imaginal discs dissected
from wandering larvae with large clones expressing UAS-GFP (controls) or
UAS-dmyc. Clones were generated with the flp-out Act > Gal4 system with
a 15 min heat shock at 37C at 72 hr AEL; with this protocol the majority of
the disc was GFP positive. RT to produce single-stranded cDNA was
performed using 1 mg total RNA and SuperScript First-Strand Synthesis kit
(Invitrogen). Q-PCRs were performed on an ABI 7300 instrument using
SYBR Green PCR Master Mix (Applied Biosystems) per manufacturer’sDevelopminstructions. For each primer set (act5C and yki), a standard curve was
produced using serially diluted cDNA made from WT imaginal discs. In
analyzing Q-PCRs, primer appropriate standard curves were used to calculate
relative cDNA concentration in each control and experimental sample. Primers
to act5C were used as loading control and to normalize the data.
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